Trial Profile
Comparison of the efficacy and safety of infliximab, as monotherapy or in combination with azathioprine, versus azathioprine monotherapy in moderate to severe active ulcerative colitis (part 1) comparison of maintenance versus intermittent infliximab treatment in maintaining remission: a follow-up of efficacy and safety (part 2).
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs Infliximab (Primary) ; Azathioprine
- Indications Ulcerative colitis
- Focus Registrational; Therapeutic Use
- Acronyms UC SUCCESS
- Sponsors Merck Sharp & Dohme; Schering-Plough
- 21 Jun 2019 Trial has been discontinued in France.
- 13 Jun 2019 Trial has been discontinued in UK and Spain.
- 26 Oct 2011 Results presented at the 19th United European Gastroenterology Week.